Cabozantinib Impurity 31 | CAS 202917-05-3 - Request Quote
Cabozantinib Impurity 31
| SZ CAT No: | SZ-C112047 |
| CAS No | 202917-05-3 |
| Mol.F. | C17H14N2O5 |
| Mol.Wt. | 326.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cabozantinib Impurity 31 is chemically 6,7-Dimethoxy-4-(3-nitrophenoxy)quinoline. Cabozantinib Impurity 31 is supplied with detailed characterization data compliant with regulatory guideline. Cabozantinib Impurity 31 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cabozantinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 202917-05-3
Purchase 202917-05-3
Order 202917-05-3
Enquire 202917-05-3
price of 202917-05-3
202917-05-3 Supplier
202917-05-3 Manufacturer
202917-05-3 Exporter
buy high quality Cabozantinib Impurity 31
Purchase Cabozantinib Impurity 31
Cabozantinib Impurity 31 suppliers
Cabozantinib Impurity 31 manufacturers
Cabozantinib Impurity 31 price
Order Cabozantinib Impurity 31
Enquire Cabozantinib Impurity 31
Cabozantinib Impurity 31 cost
Cabozantinib Impurity 31 Supplier
Cabozantinib Impurity 31 Distributor
Cabozantinib Impurity 31 for Method Validation
Cabozantinib Reference Standard
Cabozantinib Impurity 31 for ANDA Filing
Cabozantinib Impurity 31 for Forced Degradation Studies
Cabozantinib Impurity 31 Identification Standards
Cabozantinib Impurity 31 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


